IL6 and colitis: In our results, we demonstrated that repeated EA intervention ameliorates DSS-induced colitis by suppressing proinflammatory mediators, including CRP, IFN-γ, TNF-α, and IL-6 through the TLR4 signaling via MyD88-dependent pathway.